Are two doses of misoprostol after mifepristone for early abortion better than one?

被引:20
|
作者
Coyaji, K.
Krishna, U.
Ambardekar, S.
Bracken, H.
Raote, V.
Mandlekar, A.
Winikoff, B.
机构
[1] Gynuity Hlth Projects, New York, NY 10010 USA
[2] KEM Hosp, Dept Obstet & Gynaecol, Pune, Maharashtra, India
[3] Larsen & Toubro Hlth Ctr, Bombay, Maharashtra, India
关键词
India; medical abortion; mifepristone; misoprostol; EARLY MEDICAL ABORTION; EARLY-PREGNANCY TERMINATION; RANDOMIZED-TRIAL; VAGINAL MISOPROSTOL; UNITED-STATES; EFFICACY; ACCEPTABILITY; WOMEN; GESTATION; REGIMENS;
D O I
10.1111/j.1471-0528.2006.01208.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The objective of this study was to determine if a repeat dose of misoprostol following mifepristone or a single dose of misoprostol increases the efficacy of medical termination of pregnancy. Design Randomised, placebo controlled trial. Setting K.E.M. Hospital, Pune, India, and the Health Centre, Larsen and Toubro Limited, Mumbai, India. Sample A total of 300 women seeking an abortion with amenorrhoea of 8 weeks or less. Methods Women were randomised to receive one or two doses of 400 microgram oral misoprostol at the clinic 48 hours after administration of 200 mg mifepristone. Main outcome measure Complete abortion without surgical intervention. Results The repeat administration of misoprostol 400 microgram improved the complete abortion rate from 86 to 92% and significantly reduced the rate of continuing pregnancy from 7 to 1%. Almost all the women who were administered the additional dose of misoprostol were either very satisfied (58%) or satisfied (37%) with the method. Conclusion While an additional oral dose of 400 microgram misoprostol did not significantly increase the rate of complete abortion without surgical intervention, the additional dose did significantly reduce the rate of continuing pregnancies without compromising the acceptability and ease of use of the method.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 50 条
  • [31] Varicella vaccine - Are two doses better than one?
    Gershon, AA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (24): : 1962 - 1963
  • [32] Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol
    Reeves, Matthew F.
    Monmaney, Jessica A.
    Creinin, Mitchell D.
    CONTRACEPTION, 2016, 93 (02) : 119 - 125
  • [33] UTERINE CONTRACTILITY AND INDUCTION OF ABORTION IN EARLY-PREGNANCY BY MISOPROSTOL AND MIFEPRISTONE
    NORMAN, JE
    THONG, KJ
    BAIRD, DT
    LANCET, 1991, 338 (8777): : 1233 - 1236
  • [34] Hematosalpinx: an unusual complication after medical abortion with oral mifepristone and misoprostol
    Lin, SK
    Ho, ESC
    Chen, YJ
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 25 (04) : 416 - 417
  • [35] Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials
    Raghavan, Sheila
    Maistruk, Galina
    Shochet, Tara
    Bannikov, Vladimir
    Posohova, Svetlana
    Zhuk, Svetlana
    Lishchuk, Vladimir
    Winikoff, Beverly
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02): : 112 - 119
  • [36] Mobius syndrome in a neonate after mifepristone and misoprostol elective abortion failure
    Bos-Thompson, Marie-Andree
    Hillaire-Buys, Dominique
    Roux, Clarisse
    Faillie, Jean-Luc
    Amram, Daniel
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (06) : 888 - 892
  • [37] Comparative study between two different doses of sublingual misoprostol following mifepristone in early pregnancy termination
    Priyanka, H. K.
    Prabhu, S.
    Shetty, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 14 - 14
  • [38] EARLY INDUCTION OF ABORTION BY A COMBINATION OF ORAL MIFEPRISTONE AND MISOPROSTOL ADMINISTERED BY THE VAGINAL ROUTE
    ELREFAEY, H
    TEMPLETON, A
    CONTRACEPTION, 1994, 49 (02) : 111 - 114
  • [39] Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial
    von Hertzen, H.
    Piaggio, G.
    Wojdyla, D.
    Marions, L.
    My Huong, N. T.
    Tang, O. S.
    Fang, A. H.
    Wu, S. C.
    Kalmar, L.
    Mittal, S.
    Erdenetungalag, R.
    Horga, M.
    Pretnar-Darovec, A.
    Kapamadzija, A.
    Dickson, K.
    Anh, N. D.
    Tai, N. V.
    Tuyet, H. T. D.
    Peregoudov, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (03) : 381 - 389
  • [40] Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States
    Hausknecht, R
    CONTRACEPTION, 2003, 67 (06) : 463 - 465